Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven G Reed

Showing results (21-30 of 263) with videos related to

Pageof 27
Sort By:
Trends in Immunology|December 9, 2008
New horizons in adjuvants for vaccine developmentSteven G Reed, Sylvie Bertholet, Rhea N Coler, et al.
Sub-Cellular Biochemistry|July 2, 2010
Synthetic and natural TLR4 agonists as safe and effective vaccine adjuvantsChristopher B Fox, Martin Friede, Steven G Reed, et al.
Current Opinion in Immunology|July 9, 2016
The science of vaccine adjuvants: advances in TLR4 ligand adjuvantsSteven G Reed, Fan-Chi Hsu, Darrick Carter, et al.
Current Opinion in Immunology|April 24, 2012
Adjuvants for human vaccinesCarl R Alving, Kristina K Peachman, Mangala Rao, et al.
Acta Tropica|March 28, 2003
Leishmania model for microbial virulence: the relevance of parasite multiplication and pathoantigenicityKwang-Poo Chang, Steven G Reed, Bradford S McGwire, et al.
Vaccine|November 17, 2011
The development and clinical evaluation of second-generation leishmaniasis vaccinesMalcolm S Duthie, Vanitha S Raman, Franco M Piazza, et al.
Immunological Reviews|January 5, 2011
Use of defined TLR ligands as adjuvants within human vaccinesMalcolm S Duthie, Hillarie Plessner Windish, Christopher B Fox, et al.
Infection and Immunity|June 23, 2006
Cloning, characterization, and serodiagnostic evaluation of Leishmania infantum tandem repeat proteinsYasuyuki Goto, Rhea N Coler, Jeffrey Guderian, et al.
Biogerontology|May 10, 2015
The stimulatory effect of the TLR4-mediated adjuvant glucopyranosyl lipid A is well preserved in old ageBirgit Weinberger, Clemens Joos, Steven G Reed, et al.
Memorias Do Instituto Oswaldo Cruz|January 4, 2013
Serologic follow-up of IgG responses against recombinant mycobacterial proteins ML0405, ML2331 and LID-1 in a leprosy hyperendemic area in VenezuelaElsa Rada, Malcolm S Duthie, Steven G Reed, et al.
Pageof 27

Showing results (21-30 of 263) with videos related to

Sort By:
Pageof 27
Trends in Immunology|December 9, 2008
New horizons in adjuvants for vaccine developmentSteven G Reed, Sylvie Bertholet, Rhea N Coler, et al.
Sub-Cellular Biochemistry|July 2, 2010
Synthetic and natural TLR4 agonists as safe and effective vaccine adjuvantsChristopher B Fox, Martin Friede, Steven G Reed, et al.
Current Opinion in Immunology|July 9, 2016
The science of vaccine adjuvants: advances in TLR4 ligand adjuvantsSteven G Reed, Fan-Chi Hsu, Darrick Carter, et al.
Current Opinion in Immunology|April 24, 2012
Adjuvants for human vaccinesCarl R Alving, Kristina K Peachman, Mangala Rao, et al.
Acta Tropica|March 28, 2003
Leishmania model for microbial virulence: the relevance of parasite multiplication and pathoantigenicityKwang-Poo Chang, Steven G Reed, Bradford S McGwire, et al.
Vaccine|November 17, 2011
The development and clinical evaluation of second-generation leishmaniasis vaccinesMalcolm S Duthie, Vanitha S Raman, Franco M Piazza, et al.
Immunological Reviews|January 5, 2011
Use of defined TLR ligands as adjuvants within human vaccinesMalcolm S Duthie, Hillarie Plessner Windish, Christopher B Fox, et al.
Infection and Immunity|June 23, 2006
Cloning, characterization, and serodiagnostic evaluation of Leishmania infantum tandem repeat proteinsYasuyuki Goto, Rhea N Coler, Jeffrey Guderian, et al.
Biogerontology|May 10, 2015
The stimulatory effect of the TLR4-mediated adjuvant glucopyranosyl lipid A is well preserved in old ageBirgit Weinberger, Clemens Joos, Steven G Reed, et al.
Memorias Do Instituto Oswaldo Cruz|January 4, 2013
Serologic follow-up of IgG responses against recombinant mycobacterial proteins ML0405, ML2331 and LID-1 in a leprosy hyperendemic area in VenezuelaElsa Rada, Malcolm S Duthie, Steven G Reed, et al.
Pageof 27